BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

  Shockwave Medical, Inc. announced today that the company will be participating in the SVB Leerink 11th Annual Global Healthcare Conference, scheduled to be held virtually from February 14-18, 2022.

  February 4, 2022

   · 

  1 min read
• Alimera Sciences to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference

  Alimera Sciences, Inc. today announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer will present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference, which is being held virtually from February 8 – 11, 2022.

  February 4, 2022

   · 

  1 min read
• Drug Development

  Revolo Biotherapeutics Receives MHRA Approval for Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in the United Kingdom

  Revolo Biotherapeutics today announced that it has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to commence two Phase 2 clinical trials to evaluate its immune-resetting drug candidate.

  February 4, 2022

   · 

  3 min read
• SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting

  SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual analyst and investor meeting today, February 4th , 2022, from 10:00 a.m. to approximately 1:00 p.m. Eastern Time.

  February 4, 2022

   · 

  4 min read
• /R E P E A T - NOTICE TO THE MEDIA - The Minister of Health and Government of Canada officials to hold a news conference on coronavirus disease (February 4, 2022)/

  The Honourable Jean-Yves Duclos, Minister of Health, and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

  February 4, 2022

   · 

  1 min read
• Business

  MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY

  Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2021.

  February 4, 2022

   · 

  17 min read
• Encompass Health to participate in the SVB Leerink 11th Annual Virtual Global Healthcare Conference

  Encompass Health Corp. (NYSE: EHC) today announced it will participate in the SVB Leerink 11th Annual Virtual Global Healthcare Conference taking place February 14-18, 2022.

  February 4, 2022

   · 

  1 min read
• Genetown

  Hemab Therapeutics Announces First Drug Candidate: HMB-001, a Novel Bispecific Antibody with Potential for Treatment of Rare Bleeding Disorders

  Preclinical data demonstrate HMB-001’s promise as a preventative treatment for patients with underserved bleeding disorders, including Glanzmann Thrombasthenia.

  February 4, 2022

   · 

  3 min read
• Deals

  OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination

  Investor Call Rescheduled to Tuesday, Feb. 8 at 8:30 a.m. EST to Discuss Combination between Comera Life Sciences, Inc. and OTR Acquisition Corp.

  February 4, 2022

   · 

  6 min read
• Business

  Amneal to Report Fourth Quarter and Full Year 2021 Results on March 2, 2022

  Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced today that the Company will release its fourth quarter and full year 2021 financial results on Wednesday, March 2, 2022, prior to market open.

  February 4, 2022

   · 

  1 min read